Charles River Laboratories International (CRL) News Today → Trump’s Gift Could Unleash $51 Billion in New Wealth (From Wealthpin Pro) (Ad) Free CRL Stock Alerts $214.79 -6.83 (-3.08%) (As of 06/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 8 at 9:49 AM | marketbeat.comMorningstar Investment Services LLC Purchases 51,110 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Morningstar Investment Services LLC grew its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 99.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 102,626 shares of the mediJune 8 at 2:50 AM | americanbankingnews.comCharles River Laboratories International (NYSE:CRL) Stock Rating Upgraded by StockNews.comJune 7 at 8:40 AM | marketbeat.comPublic Employees Retirement Association of Colorado Sells 37,050 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Public Employees Retirement Association of Colorado reduced its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 43.9% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund ownedJune 7 at 7:40 AM | americanbankingnews.comCharles River Laboratories International (NYSE:CRL) Coverage Initiated at MizuhoJune 7 at 5:10 AM | americanbankingnews.comCharles River Laboratories International (NYSE:CRL) Coverage Initiated by Analysts at The Goldman Sachs GroupJune 6 at 10:13 PM | marketbeat.comCharles River Laboratories International (NYSE:CRL) Upgraded to Buy at StockNews.comStockNews.com upgraded shares of Charles River Laboratories International from a "hold" rating to a "buy" rating in a report on Thursday.June 6 at 11:57 AM | globenewswire.comCRL INVESTIGATION ALERT: Johnson Fistel LLP Investigates Charles River Laboratories' Directors and Officers for Breach of Fiduciary DutiesJune 6 at 8:43 AM | marketbeat.comArmistice Capital LLC Sells 120,000 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Armistice Capital LLC decreased its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 76.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 36,000 shares of the medical reseaJune 6 at 7:30 AM | marketbeat.comCharles River Laboratories International (NYSE:CRL) Now Covered by Analysts at The Goldman Sachs GroupThe Goldman Sachs Group assumed coverage on shares of Charles River Laboratories International in a research report on Thursday. They issued a "buy" rating and a $290.00 target price on the stock.June 6 at 12:50 AM | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Holdings Raised by Pinebridge Investments L.P.Pinebridge Investments L.P. lifted its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 23.1% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 100,381 shares of the medical research compaJune 4, 2024 | marketbeat.comBell Asset Management Ltd Sells 6,868 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Bell Asset Management Ltd trimmed its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 13.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 43,439 shares of the mediJune 4, 2024 | americanbankingnews.comCharles River Laboratories International, Inc. (NYSE:CRL) Sees Significant Drop in Short InterestJune 3, 2024 | marketbeat.comNicholas Company Inc. Has $16.71 Million Position in Charles River Laboratories International, Inc. (NYSE:CRL)Nicholas Company Inc. increased its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 17.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 70,681 shares of the medical reseJune 3, 2024 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Position Increased by Meritage Group LPMeritage Group LP boosted its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 30.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,155,376 shares of the medical reJune 2, 2024 | marketbeat.comShort Interest in Charles River Laboratories International, Inc. (NYSE:CRL) Drops By 8.4%Charles River Laboratories International, Inc. (NYSE:CRL - Get Free Report) was the recipient of a significant drop in short interest during the month of May. As of May 15th, there was short interest totalling 1,740,000 shares, a drop of 8.4% from the April 30th total of 1,900,000 shares. Based on an average trading volume of 516,900 shares, the short-interest ratio is presently 3.4 days.June 2, 2024 | americanbankingnews.comCharles River Laboratories International, Inc. (NYSE:CRL) Given Consensus Rating of "Moderate Buy" by BrokeragesJune 2, 2024 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Given Consensus Rating of "Moderate Buy" by AnalystsShares of Charles River Laboratories International, Inc. (NYSE:CRL - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the eleven ratings firms that are presently covering the stock, Marketbeat.com reports. Four analysts have rated the stock with a hold recommendaJune 1, 2024 | americanbankingnews.comQ2 2024 EPS Estimates for Charles River Laboratories International, Inc. Decreased by Analyst (NYSE:CRL)May 31, 2024 | marketbeat.comBrokers Set Expectations for Charles River Laboratories International, Inc.'s Q2 2024 Earnings (NYSE:CRL)Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) - Equities research analysts at Zacks Research reduced their Q2 2024 EPS estimates for shares of Charles River Laboratories International in a research note issued to investors on Thursday, May 30th. Zacks Research analyst R.May 31, 2024 | seekingalpha.comCharles River Laboratories: Fair Valuation Against FundamentalsMay 30, 2024 | businesswire.comCharles River Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy DevelopmentMay 30, 2024 | marketbeat.comCharles River Laboratories International Q1 Earnings TranscriptMay 30, 2024 | marketbeat.comCorient Private Wealth LLC Boosts Stake in Charles River Laboratories International, Inc. (NYSE:CRL)Corient Private Wealth LLC raised its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 114.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 13,358 sharesMay 28, 2024 | businesswire.comTitian Receives Multi-Year Commitment from Charles River for Mosaic Sample Management SoftwareMay 25, 2024 | marketbeat.com428,592 Shares in Charles River Laboratories International, Inc. (NYSE:CRL) Acquired by Norges BankNorges Bank purchased a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 428,592 shares of the medical research company's stock, valued at approximately $101May 25, 2024 | marketbeat.comCharles River Laboratories International (NYSE:CRL) Cut to "Hold" at StockNews.comStockNews.com cut shares of Charles River Laboratories International from a "buy" rating to a "hold" rating in a research note on Saturday.May 24, 2024 | marketbeat.comDai ichi Life Insurance Company Ltd Trims Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Dai ichi Life Insurance Company Ltd cut its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 65.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 9,430 shares of the medicaMay 23, 2024 | marketbeat.comFranklin Resources Inc. Decreases Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Franklin Resources Inc. reduced its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 2.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 763,015 shares of theMay 22, 2024 | marketbeat.comGW&K Investment Management LLC Increases Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)GW&K Investment Management LLC grew its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 21.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 55,510 shares ofMay 21, 2024 | marketbeat.comKing Luther Capital Management Corp Decreases Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)King Luther Capital Management Corp trimmed its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 4.9% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 366,834 shares of the medical research companMay 20, 2024 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Clearbridge Investments LLCClearbridge Investments LLC lowered its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 15.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,468,059 shares ofMay 18, 2024 | marketbeat.comJackson Square Partners LLC Acquires 80,873 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Jackson Square Partners LLC increased its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 30.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 349May 16, 2024 | marketbeat.comCharles River Laboratories International (NYSE:CRL) Shares Down 4.1% Charles River Laboratories International (NYSE:CRL) Stock Price Down 4.1%May 16, 2024 | insidertrades.comJoseph W. Laplume Sells 1,304 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) StockMay 14, 2024 | marketbeat.comCuri Wealth Management LLC Decreases Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Curi Wealth Management LLC lowered its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 17.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 40,018 shares oMay 14, 2024 | marketbeat.comInsider Selling: Charles River Laboratories International, Inc. (NYSE:CRL) EVP Sells 1,304 Shares of StockCharles River Laboratories International, Inc. (NYSE:CRL - Get Free Report) EVP Joseph W. Laplume sold 1,304 shares of the stock in a transaction dated Friday, May 10th. The stock was sold at an average price of $226.97, for a total transaction of $295,968.88. Following the transaction, the executive vice president now directly owns 23,276 shares of the company's stock, valued at approximately $5,282,953.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.May 14, 2024 | gurufocus.comInsider Sale: EVP Joseph Laplume Sells Shares of Charles River Laboratories International Inc (CRL)May 13, 2024 | marketbeat.comCharles River Laboratories International (NYSE:CRL) Price Target Cut to $228.00TD Cowen decreased their price target on shares of Charles River Laboratories International from $260.00 to $228.00 and set a "hold" rating on the stock in a research note on Monday.May 13, 2024 | markets.businessinsider.comCharles Rhyee Maintains Hold on Charles River Labs Amidst Revenue and Market UncertaintiesMay 12, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Acquires 21,028 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Charles Schwab Investment Management Inc. grew its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 4.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 513,227 shares of the medical researMay 11, 2024 | marketbeat.comMawer Investment Management Ltd. Buys 7,014 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Mawer Investment Management Ltd. boosted its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 36.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 26,025 shares of the medicaMay 10, 2024 | marketbeat.comTimesSquare Capital Management LLC Invests $7.53 Million in Charles River Laboratories International, Inc. (NYSE:CRL)TimesSquare Capital Management LLC purchased a new stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 31,835 shares of the medical research company's stock, valueMay 9, 2024 | markets.businessinsider.comCharles River Laboratories Reaffirms FY24 Outlook; Q1 Results Top EstimatesMay 9, 2024 | msn.comCharles River Laboratories Non-GAAP EPS of $2.27 beats by $0.21, revenue of $1.01B beats by $16.54MMay 9, 2024 | finance.yahoo.comCharles River Laboratories Announces First-Quarter 2024 ResultsMay 9, 2024 | finance.yahoo.comCharles River beats first-quarter estimates, reaffirms annual forecastMay 9, 2024 | marketbeat.comCharles River Laboratories International (NYSE:CRL) Issues FY 2024 Earnings GuidanceCharles River Laboratories International (NYSE:CRL) updated its FY 2024 earnings guidance. The company provided EPS guidance of 10.900-11.400 for the period, compared to the consensus estimate of 11.020. The company also issued revenue guidance of $4.2 billionillion-$4.3 billionillion, compared to the consensus estimate of $4.2 billionillion.May 9, 2024 | marketbeat.comRussell Investments Group Ltd. Grows Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Russell Investments Group Ltd. boosted its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 17.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor ownMay 8, 2024 | marketbeat.comEverpar Advisors LLC Takes Position in Charles River Laboratories International, Inc. (NYSE:CRL)Everpar Advisors LLC bought a new stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 3,884 shares of the medical researchMay 7, 2024 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Stock Holdings Lowered by National Bank of Canada FINational Bank of Canada FI trimmed its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 15.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 103,774 shares of the medical research co Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address The Only Energy Play You Should Be Looking At (Ad)Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy. Click here to get all the information about it. CRL Media Mentions By Week CRL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRL News Sentiment▼0.670.74▲Average Medical News Sentiment CRL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRL Articles This Week▼206▲CRL Articles Average Week Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Agilent Technologies News Mettler-Toledo International News Waters News Illumina News Bio-Techne News Bruker News Bio-Rad Laboratories News Pacific Biosciences of California News Harvard Bioscience News aTyr Pharma News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:CRL) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredWarren Buffett & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | Sponsored